Tradestie Institutional Equity Comparison Engine

CRBP vs SRZN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CRBP trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus SRZN at N/M Forward P/E and -485.4% operating margin (+408.6% YoY). In options structure, CRBP sits in BREAKDOWN (66th %ile IV; Dealer Gamma Walls on Pro) against SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CRBP N/M vs SRZN N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin 0.0% vs -485.4% ยท YoY -100.0% vs +408.6%
Momentum & Technical Winner SRZN
1Y -69.5% vs +166.7% ยท 52W Pos 6% vs 79%
Options & Structure Winner SRZN
BREAKDOWN (66th %ile IV) vs CONSOLIDATION (5th %ile IV)
CRBP NASDAQ
Corbus Pharmaceuticals Holdings, Inc.
Pharmaceutical Preparations
$3.38
-0.44% 1D
Market Cap $69.9M
1M Return -25.33%
1Y Return -69.51%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 43.0 Fund 54.0 Flow 69.0 Mom 64.0
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$32.32
+2.25% 1D
Market Cap $602.5M
1M Return +37.88%
1Y Return +166.67%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 5.0 Fund 32.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRBP -69.51% SRZN +166.67% Spread: +236.18 pp (SRZN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRBP Revenue SRZN Revenue CRBP Op. Margin SRZN Op. Margin Margin Edge
FY2017 $0M N/A -1334.4% N/A CRBP
FY2018 $0M N/A -1176.8% N/A CRBP
FY2019 $40M N/A -213.3% N/A CRBP
FY2020 $0M N/A -3119.2% N/A CRBP
FY2021 $0M N/A -6350.1% N/A CRBP
FY2022 N/A $10M N/A -354.7% SRZN
FY2024 N/A $10M N/A -239.7% SRZN
FY2025 N/A $0M N/A -1210.6% SRZN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRBP (2) vs SRZN (5)
Institutional Metric CRBP SRZN Criterion Row Winner
Market Capitalization Scale $69.9M $602.5M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +408.6% Higher Growth SRZN
Operating Margin (TTM) Profitability 0.0% -485.4% Higher Margin CRBP
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -131.5% -62.8% Higher ROE SRZN
52-Week Range Position Momentum 6% ($3โ€“$13) 79% ($12โ€“$38) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 1.93ฮฒ ยท 121% Vol 1.21ฮฒ ยท 62% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite CRBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRBP vs SRZN Buy Guide
CRBP BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 66th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live CRBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRZN CONSOLIDATION
37d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRBP nor SRZN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.